FUSION ANTIBODIES PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.35 GBX | -2.90% |
|
-1.47% | -21.18% |
| 30/04 | EARNINGS AND TRADING: Software Circle & Beximco report higher revenue | AN |
| 15/04 | Fusion Antibodies inks commercial contract for OptiPhage library | AN |
Quotes 5-day view
Delayed Quote London S.E.| 15/05/2024 | 16/05/2024 | 17/05/2024 | 20/05/2024 | 21/05/2024 | |
|---|---|---|---|---|---|
| Last | 3.5 p | 3.45 p | 3.4 p | 3.45 p | 3.35 p |
| Volume | 742 043 | 751 624 | 337 987 | 653 673 | 2 529 093 |
| Change | +2.94% | -1.43% | -1.45% | +1.47% | -2.90% |
| Opening | 3.40 | 3.50 | 3.45 | 3.40 | 3.45 |
| High | 3.60 | 3.80 | 3.47 | 3.50 | 3.6 |
| Low | 3.30 | 3.20 | 3.23 | 3.30 | 3.302 |
Performance
| 1 day | -2.90% | ||
| 1 week | -1.47% | ||
| Current month | +3.88% | ||
| 1 month | -11.84% | ||
| 3 months | -17.28% | ||
| 6 months | -1.47% | ||
| Current year | -21.18% | ||
| 1 year | -48.46% | ||
| 3 years | -97.42% | ||
| 5 years | -94.17% |
Volumes
marketsDaily volume
2 529 093
Estimated daily volume
2 529 093
Avg. Volume 20 sessions
771 295
Daily volume ratio
3.28
Avg. Volume 20 sessions GBX
2 583 838.25
Avg. Volume 20 sessions USD
2 583 838.25
Record volume 1
22 763 250
Record volume 2
12 318 310
Record volume 3
10 827 540
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Capitalization (GBX)
3 288 239
Capitalization (USD)
4 180 042
Net sales (GBP)
2 901 000
Net sales (USD)
3 687 780
Number of employees
48
Sales / Employee (GBP)
60 438
Sales / Employee (USD)
76 829
Free-Float
89.63 %
Free-Float capitalization (GBX)
2 947 388
Free-Float capitalization (USD)
3 746 749
Average Daily Capital Traded
78.58%
Highs and lows
1 week
3.20
3.80
1 month
3.123.90
Current year
3.128.50
1 year
3.0210.00
3 years
3.02149.25
5 years
3.02250.00
10 years
3.02250.00
Indicators
Moving average 5 days
3.44
Moving average 20 days
3.50
Moving average 50 days
3.75
Moving average 100 days
4.10
Price spread / (MMA5)
+2.69%
Price spread / (MMA20)
+4.55%
Price spread / (MMA50)
+11.79%
Price spread / (MMA100)
+22.45%
STIM
RSI 9 days
39.88
RSI 14 days
39.76
Sector Comparison - Other Biotechnology & Medical Research
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -2.90% | -1.47% | -21.18% | -48.46% | 4.18M | ||
| -1.24% | +8.30% | +39.74% | +9.65% | 54.04B | ||
| -4.04% | +0.08% | +43.57% | -12.02% | 41.96B | ||
| -0.60% | -1.03% | -1.14% | +13.37% | 41.92B | ||
| -0.43% | -2.41% | -7.59% | +7.07% | 28.35B | ||
| +0.00% | +1.15% | +12.76% | +47.83% | 26.35B | ||
| -0.85% | +0.83% | -22.09% | -22.76% | 19B | ||
| +0.80% | -1.21% | +7.74% | -1.28% | 13B | ||
| -0.83% | -1.45% | +28.13% | +87.42% | 12.28B | ||
| +0.02% | +1.75% | +24.83% | +25.58% | 12.19B | ||
| -0.89% | -4.98% | -6.42% | +9.88% | 11.49B | ||
| -1.00% | -0.84% | +0.53% | -2.85% | 10.09B | ||
| -0.94% | +5.28% | +38.08% | -7.62% | 7.47B | ||
| -3.77% | +3.50% | +34.90% | +44.96% | 6.6B | ||
| -0.45% | +0.81% | +5.78% | -35.06% | 6.55B | ||
| -1.64% | -2.91% | +11.00% | +82.03% | 6.53B | ||
| Average | -1.18% | +2.27% | +11.79% | +12.36% | ||
| Weighted average by Cap. | -1.20% | +2.97% | +16.57% | +12.10% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
6d5a826b30.CdT8tOYbEWSTsdiu0Ig9h7M_JUQ4l-Uqhkdz2J-JMa0.bLCz5aNwewKk_JHgt8JPsdVnZw5Ax9V43CQUitHICc44sKThkk11NN3jmQ
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 08:59:37 pm | 3.39 | 30 | 2,129,093 |
| 08:59:17 pm | 3.39 | 29 | 2,129,063 |
| 08:59:02 pm | 3.378 | 38,200 | 2,129,034 |
| 08:58:59 pm | 3.302 | 30,000 | 2,090,834 |
| 08:54:24 pm | 3.333 | 150,000 | 2,060,834 |
| 08:52:53 pm | 3.39 | 147 | 1,910,834 |
| 08:08:12 pm | 3.39 | 30 | 1,910,687 |
| 08:05:46 pm | 3.35 | 59,344 | 1,910,657 |
| 07:29:35 pm | 3.35 | 36 | 1,851,313 |
Monthly variations
Annual change
| 2024 | -18.82% | ||
| 2023 | -90.56% | ||
| 2022 | -59.09% | ||
| 2021 | -11.29% | ||
| 2020 | +57.96% | ||
| 2019 | +44.04% | ||
| 2018 | -74.41% | ||
| 2017 | +72.47% |
- Stock Market
- Equities
- FAB Stock
- Quotes Fusion Antibodies plc